Bob Fiddaman said
I can see no benefit of Seroxat, none whatsoever. The longer it remains on the market will mean countless suffering for people on other SSRi's. Once removed, it will open the doors for other SSRi's to be thoroughly investigated and maybe other bloggers, campaigners, advocates can start banging the drum and asking the regulator about Prozac, Zoloft and other SSRi related drugs.
http://fiddaman.blogspot.com/2009/08/seroxat-in-media.html
http://fiddaman.blogspot.com/2009/08/seroxat-in-media.html
No comments:
Post a Comment
Note: only a member of this blog may post a comment.